Evidence map›Paper›PMID 33640678›Full record

ArticleDrug and alcohol dependence2021

Effects of daily Δ

Sarah L Withey, Brian D Kangas, Sophia Charles, Andrew B Gumbert, Jessica E Eisold, Susan R George, Jack Bergman, Bertha K Madras

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Chronic ΔBritish journal of pharmacology · 2025
    Article
  3. Article
  4. Chronic ΔNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  5. Review
  6. Review
  7. Consequences of adolescent drug use.Translational psychiatry · 2023
    Review
  8. Article
  9. Mechanisms of cannabinoid tolerance.Biochemical pharmacology · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Effects of Cannabidiol on Locomotor Activity.Life (Basel, Switzerland) · 2022
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah L WitheyLaboratory of Addiction Neurobiology, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA; Behavioral Biology Program, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA; Department of Psychiatry, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA.
Brian D KangasBehavioral Biology Program, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA; Department of Psychiatry, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA.
Sophia CharlesLaboratory of Addiction Neurobiology, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA.
Andrew B GumbertLaboratory of Addiction Neurobiology, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA.
Jessica E EisoldLaboratory of Addiction Neurobiology, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA.
Susan R GeorgeDepartment of Pharmacology, University of Toronto, Toronto, ON, M5S 1A8, Canada.
Jack BergmanBehavioral Biology Program, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA; Department of Psychiatry, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA.
Bertha K MadrasLaboratory of Addiction Neurobiology, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA; Department of Psychiatry, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA; Department of Medicine, University of Toronto, Toronto, ON, M5S 1A8, Canada. Electronic address: bertha_madras@hms.harvard.edu.

Funding

Long Term THC Elicits Distinct Changes in Adolescent Brain Dopamine SignalingR01DA042178 · NIDA · MCLEAN HOSPITAL · PI MADRAS, BERTHA K · 2017 to 2021
$2.8M
NIDA NIH HHS R01 DA042178
6 · The paper itself

Abstract

backgroundDaily use of marijuana is rising in adolescents, along with consumption of high potency marijuana products (high % Δ-9-tetrahydrocannabinol or THC). These dual, related trends have opened gaps in understanding the long-term effects of daily consumption of a high dose of THC in adolescents and whether a therapeutic dose of cannabidiol (CBD) modulates THC effects.

methodsAdolescent squirrel monkeys (Saimiri boliviensis) were treated daily for four months with vehicle (n = 4), a high THC dose (1 mg/kg i.m.; n = 4), or THC + CBD (1 mg/kg +3 mg/kg i.m.; n = 4), to investigate whether: (1) a daily high THC dose affects performance in tasks of cognition (repeated acquisition, discrimination reversal); (2) a daily high THC dose affects spontaneous behavior and day/night activity (3) tolerance develops to the behavioral effects of THC; (4) whether CBD modulates THC effects.

resultsTHC impaired performance of adolescent monkeys in a cognitive test initially, but not performance on a task of cognitive flexibility. THC reduced motor activity and increased sedentary behavior, with tolerance developing after weeks of daily treatment. Co-administered with THC, CBD did not modulate THC effects on cognitive performance, activity or tolerance, but prevented THC-induced emesis on the first day of daily treatment.

conclusionsDaily high dosing with THC compromised performance on a task of cognition, and reduced activity in adolescent primates, with tolerance developing within weeks. Whether our observations are relevant to a broader range of cognitive tasks vital for daily function in human adolescents is uncertain.

Indexed as

AnimalsBehavior, AnimalCannabidiolCognitionDose-Response Relationship, DrugDronabinolDrug ToleranceHallucinogensModels, AnimalPsychomotor PerformanceSaimiriTask Performance and AnalysisCannabidiolDronabinolHallucinogensAdolescent monkeysCannabidiolCannabisCBDCognitionEmesisMarijuanaNonhuman primatesSleepTHCUnconditioned behaviorΔ9-Tetrahydrocannabinol

Identifiers

PMID33640678
PMCPMC8204682

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.